|
Saturday, 14 March 2009 15:23 |
|
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) today reported its results for the fourth quarter and full year 2008. In 2008, NPS initiated two Phase 3 registration studies – STEPS for GATTEX™ (teduglutide) in short bowel syndrome (SBS) and REPLACE for NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) in hypoparathyroidism. |
|
Read more...
|
|
Friday, 13 March 2009 22:17 |
|
An antibody with the potential to stop breast cancer in its path. A nanoparticle that can address a side effect of the treatment that hemophiliacs cannot live without. A "quantum dot" with the potential to treat cancer or harvest the power of the sun. An air purifier that kills the world's nastiest toxins. |
|
Read more...
|
|
Friday, 13 March 2009 22:13 |
|
The Generic Pharmaceutical Association (GPhA) released the following statement today from GPhA President and CEO Kathleen Jaeger regarding the introduction of H.R. 1427, the Bipartisan Biogenerics Consensus Bill: "Promoting Innovation and Access to Life-Saving Medicine Act." |
|
Read more...
|
|
Friday, 13 March 2009 21:42 |
 New software developed with help from the Wildlife Conservation Society will allow tiger researchers to rapidly identify individual animals by creating a three-dimensional model using photos taken by remote cameras. The software, described in an issue of the journal Biology Letters, may also help identify the origin of tigers from confiscated skins. |
|
Read more...
|
|
Friday, 13 March 2009 21:16 |
|
Skinvisible, Inc. has announced that it has been granted a comprehensive patent in Japan for Invisicare, a product-enhancing polymer delivery system for topical dermatology products. The patent protects Invisicare in the areas of 'Topical Composition,' 'Topical Composition Precursor,' and 'Methods for Manufacturing and Using.' |
|
Read more...
|
|
Friday, 13 March 2009 19:53 |
|
Against a backdrop of a worldwide economic recession, Waters Corporation (NYSE:WAT) is demonstrating how its industry-leading analytical instruments and informatics products address today’s greatest scientific and business challenges at the 60th Pittsburgh Conference (Pittcon) on Analytical Chemistry and Applied Spectroscopy, March 8 – 13, 2009. |
|
Read more...
|
|
|
Friday, 13 March 2009 22:21 |
|
Cordex Pharma, Inc. has announced today that it has filed a formulation patent covering its lead product, ATPace. |
|
Read more...
|
|
Friday, 13 March 2009 22:15 |
|
LightSheer(R) Duet(TM) for High Speed Permanent Hair Reduction and UltraPulse 4x for Fractional C02 Rejuvenation significantly reduce treatment times to provide cost-effective-high value cosmetic options during challenging economic times. |
|
Read more...
|
|
Friday, 13 March 2009 22:05 |
 Simbionix, the world's leading developer of medical simulation systems, and VirtaMed, a Swiss medical engineering company, announced today a global collaboration agreement. Simbionix will exclusively distribute, market, and provide service for the VirtaMed HystSim, an advanced virtual reality hysteroscopy simulator. |
|
Read more...
|
|
Friday, 13 March 2009 21:34 |
|
 Genomatix Software, a company with an outstanding track record in the analysis of genomic data generated by high throughput technologies, announced today that it was issued patent No. EP 1 800 232 B1, "Identification and assignment of functionally corresponding regulatory sequences for orthologous loci in eukaryotic genomes" by the European Patent Office.
|
|
Read more...
|
|
Friday, 13 March 2009 20:00 |
|
Waters Corporation announced today that XenoTech (Lenexa, KS) has begun offering new metabolite profiling services made possible in part by its recent acquisition of a Waters® Synapt? High Definition Mass Spectrometry (HDMS) System. |
|
Read more...
|
|
|
<< Start < Prev 111 112 113 114 115 116 117 118 119 120 Next > End >>
|
|
Page 120 of 120 |
